MedTrace Logo

QuickFlex Micro Left Ventricular Lead Post Approval Study

NCT01179477 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1930

Last updated 2019-08-12

Study results available
· View outcomes & findings →

Summary

The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.

Conditions

Interventions

DEVICE

Implantation of a QuickFlex® μ Model 1258T LV Lead

Implantation of a QuickFlex® μ Model 1258T LV Pacing Lead

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Clay Cohorn · Abbott Medical Devices

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179477 on ClinicalTrials.gov